Intra-Cellular Therapies Common Stock Net 2013-2024 | ITCI
- Intra-Cellular Therapies common stock net for 2023 was $0B, a 11.11% increase from 2022.
- Intra-Cellular Therapies common stock net for 2022 was $0B, a 12.5% increase from 2021.
- Intra-Cellular Therapies common stock net for 2021 was $0B, a 0% decline from 2020.